Carmichael Hill & Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$218K Buy
2,101
+1
+0% +$102 0.08% 178
2024
Q2
$204K Sell
2,100
-599
-22% -$55.3K 0.08% 171
2024
Q1
$243K Buy
2,699
+116
+4% +$9.83K 0.1% 153
2023
Q4
$206K Sell
2,583
-323
-11% -$24.3K 0.09% 168
2023
Q3
$207K Buy
2,906
+2
+0.1% +$150 0.1% 160
2023
Q2
$224K Buy
2,904
+602
+26% +$46.6K 0.1% 154
2023
Q1
$173K Buy
2,302
+2
+0.1% +$149 0.08% 177
2022
Q4
$181K Buy
2,300
+2
+0.1% +$150 0.09% 167
2022
Q3
$161K Buy
2,298
+2
+0.1% +$157 0.09% 178
2022
Q2
$184K Sell
2,296
-798
-26% -$62.4K 0.1% 169
2022
Q1
$234K Buy
3,094
+601
+24% +$47.6K 0.11% 156
2021
Q4
$213K Buy
2,493
+2
+0.1% +$156 0.1% 172
2021
Q3
$188K Buy
2,491
+2
+0.1% +$159 0.09% 173
2021
Q2
$202K Buy
2,489
+1
+0% +$82 0.1% 165
2021
Q1
$196K Buy
2,488
+2
+0.1% +$157 0.11% 158
2020
Q4
$213K Buy
2,486
+2
+0.1% +$165 0.13% 141
2020
Q3
$192K Buy
2,484
+1
+0% +$76 0.13% 138
2020
Q2
$182K Buy
2,483
+2
+0.1% +$142 0.13% 133
2020
Q1
$165K Buy
2,481
+2
+0.1% +$141 0.14% 124
2019
Q4
$171K Buy
+2,479
New +$169K 0.12% 144

Other funds holding CL

Carmichael Hill & Associates's CL Position: Q3 2024 in Review

Carmichael Hill & Associates increased its Colgate-Palmolive (CL) stake by 0.05% in Q3 2024, buying an estimated $102 and bringing the position to 2,101 shares worth $218K. The position accounts for 0.08% of the portfolio, ranked #178.

Carmichael Hill & Associates first reported a position in CL in Q4 2019 and has held it in 20 quarters since. The position peaked at $243K in Q1 2024. 1,909 funds tracked by Wall St. Rank hold CL as of Q3 2024.

  • Carmichael Hill & Associates held 2,101 shares of Colgate-Palmolive worth $218K as of Q3 2024.
  • Carmichael Hill & Associates bought 1 Colgate-Palmolive share in Q3 2024, an estimated $102.
  • Colgate-Palmolive made up 0.08% of Carmichael Hill & Associates's portfolio in Q3 2024, its #178 holding.
  • Carmichael Hill & Associates first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 20 quarters since.
  • Carmichael Hill & Associates's Colgate-Palmolive position peaked at $243K in Q1 2024.
  • 1,909 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.